## DANIEL HAMSTRA

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Radiation Oncology  
Address| 7200 CAMBRIDGE  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Eqo%2b6GDLbqP0S5z58nriKLeBaRSOgg%3d%3d&rnd=bfc1ac38-b08b-47eb-
bbd8-5daaf2006340)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=34089599)  
  

Other Positions| Title| Chair  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Radiation Oncology  
Division| Radiation Oncology  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Dong EE, Xu J, Kim JW, Bryan J, Appleton J, **Hamstra DA** , [Ludwig MS](https://profiles.viictr.org/profile/2619439), [Hanania AN](https://profiles.viictr.org/profile/35089783). Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer. Radiat Oncol. 2024 Mar 13; 19(1):35. PMID: [38481285](//www.ncbi.nlm.nih.gov/pubmed/38481285); PMCID: [PMC10936078](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10936078).

Citations:  Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  2. Seymour ZA, Pinkawa M, Daignault-Newton S, Bosch W, Michalski JM, Gay H, **Hamstra DA**. A pooled long-term follow-up after radiotherapy for prostate cancer with and without a rectal hydrogel spacer: impact of hydrogel on decline in sexual quality of life. Front Oncol. 2023; 13:1239104. PMID: [37886176](//www.ncbi.nlm.nih.gov/pubmed/37886176); PMCID: [PMC10599244](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10599244).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37886176/citedby/)

  3. Baliga S, Patel S, Naqa IE, Li XA, Cohen LE, [Howell RM](https://profiles.viictr.org/profile/12582747), Hoppe BS, Constine LS, Palmer JD, **Hamstra D** , Olch AJ. Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):610-624. PMID: [37791936](//www.ncbi.nlm.nih.gov/pubmed/37791936).

Citations:  Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

  4. Quinn TJ, Chapman D, Parzen J, Wahl DR, McNamara A, Dess R, Chan J, Feng F, Jackson WC, **Hamstra D**. Validation of the Combination Gleason Score as an Independent Favorable Prognostic Factor in Prostate Cancer Treated With Dose-Escalated Radiation Therapy. Pract Radiat Oncol. 2023 Mar-Apr; 13(2):e166-e175. PMID: [36503624](//www.ncbi.nlm.nih.gov/pubmed/36503624).

Citations:  Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  5. Sapienza LG, Thomas JJ, [Echeverria AE](https://profiles.viictr.org/profile/23478768), Sharma S, **Hamstra DA** , [Hall TR](https://profiles.viictr.org/profile/17704783), [Ludwig MS](https://profiles.viictr.org/profile/2619439). Predictors of follow-up non-compliance after definitive radiotherapy for locally advanced cervical cancer at a community cancer center. Gynecol Oncol Rep. 2022 Dec; 44:101091. PMID: [36325116](//www.ncbi.nlm.nih.gov/pubmed/36325116); PMCID: [PMC9618769](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9618769).

Citations:

  6. Jafferji M, **Hamstra DA** , [Groth SS](https://profiles.viictr.org/profile/14348380). Stereotactic Body Radiation Therapy vs Surgery for Early-Stage Non-Small Cell Lung Cancer: Does the Dealer Influence the Choice? Ann Thorac Surg. 2023 02; 115(2):354-355. PMID: [36070808](//www.ncbi.nlm.nih.gov/pubmed/36070808).

Citations:

  7. Delaney RK, Sisco-Taylor BL, Wang X, Scherr K, [Ubel PA](https://profiles.viictr.org/profile/45106448), Haaland B, Kahn VC, **Hamstra D** , Wei JT, Madanay F, Davis JK, Greeno TU, Fagerlin A. Two Specialists, Two Recommendations: Discordance Between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations. Urology. 2022 11; 169:156-161. PMID: [35768027](//www.ncbi.nlm.nih.gov/pubmed/35768027); PMCID: [PMC10049001](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10049001).

Citations:  Fields:

Uro Urology

  8. Seymour ZA, Daignault-Newton S, McLaughlin PW, Sandler H, Jackson W, Johnson SB, Miller D, Wei J, Sanda M, **Hamstra DA**. Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment. Clin Transl Radiat Oncol. 2022 Sep; 36:56-62. PMID: [35813938](//www.ncbi.nlm.nih.gov/pubmed/35813938); PMCID: [PMC9256969](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9256969).

Citations:

  9. [Rao A](https://profiles.viictr.org/profile/34493466), Moka N, **Hamstra DA** , Ryan CJ. Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer-Where Are We Now? Cancers (Basel). 2022 Feb 04; 14(3). PMID: [35159068](//www.ncbi.nlm.nih.gov/pubmed/35159068); PMCID: [PMC8834038](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8834038).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35159068/citedby/)

  10. Campbell KC, Rehemtulla A, Sunkara P, **Hamstra D** , Buhnerkempe M, Ross B. Oral D-methionine protects against cisplatin-induced hearing loss in humans: phase 2 randomized clinical trial in India. Int J Audiol. 2022 08; 61(8):621-631. PMID: [34622731](//www.ncbi.nlm.nih.gov/pubmed/34622731).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34622731/citedby/) Fields:

Aud Audiology

  11. Scherr K, Delaney RK, [Ubel P](https://profiles.viictr.org/profile/45106448), Kahn VC, **Hamstra D** , Wei JT, Fagerlin A. Preparing Patients with Early Stage Prostate Cancer to Participate in Clinical Appointments Using a Shared Decision Making Training Video. Med Decis Making. 2022 04; 42(3):364-374. PMID: [34617827](//www.ncbi.nlm.nih.gov/pubmed/34617827); PMCID: [PMC8918874](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8918874).

Citations:  Fields:

Hea Health Services ResearchMed Medical Informatics

Translation:Humans

  12. Parzen JS, **Hamstra DA**. Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient Experience. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1129-1131. PMID: [34171237](//www.ncbi.nlm.nih.gov/pubmed/34171237).

Citations:  Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  13. Grzywacz V, Quinn TJ, Wilson T, Reitemeier P, Navin M, **Hamstra D** , Anderson J, Chinnaiyan P, Stevens C, Kabolizadeh P. Ethical Allocation of Proton Therapy and the Insurance Review Process. Pract Radiat Oncol. 2021 Sep-Oct; 11(5):e449-e458. PMID: [33548544](//www.ncbi.nlm.nih.gov/pubmed/33548544).

Citations:  Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  14. Thompson AB, **Hamstra DA**. Rectal Spacer Usage with Proton Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2020 11 01; 108(3):644-648. PMID: [32976788](//www.ncbi.nlm.nih.gov/pubmed/32976788).

Citations:  Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  15. Seymour ZA, **Hamstra DA** , Daignault-Newton S, Bosch W, Michalski J, Gay HA, Pinkawa M. Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of life. BJU Int. 2020 09; 126(3):367-372. PMID: [32333714](//www.ncbi.nlm.nih.gov/pubmed/32333714).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32333714/citedby/) Fields:

Uro Urology

Translation:HumansCTClinical Trials

  16. Levitin RB, **Hamstra DA**. Local control matters. Transl Androl Urol. 2020 Jun; 9(3):991-996. PMID: [32676381](//www.ncbi.nlm.nih.gov/pubmed/32676381); PMCID: [PMC7354304](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7354304).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32676381/citedby/)

  17. Hagan M, Kapoor R, Michalski J, Sandler H, Movsas B, Chetty I, Lally B, Rengan R, Robinson C, Rimner A, Simone C, Timmerman R, Zelefsky M, DeMarco J, **Hamstra D** , Lawton C, Potters L, Valicenti R, Mutic S, Bosch W, Abraham C, Caruthers D, Brame R, Palta JR, Sleeman W, Nalluri J. VA-Radiation Oncology Quality Surveillance Program. Int J Radiat Oncol Biol Phys. 2020 03 01; 106(3):639-647. PMID: [31983560](//www.ncbi.nlm.nih.gov/pubmed/31983560).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31983560/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  18. Quinn TJ, Daignault-Newton S, Bosch W, Mariados N, Sylvester J, Shah D, Gross E, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, DeWeese T, Gay HA, Michalski J, **Hamstra DA**. Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial. Pract Radiat Oncol. 2020 May - Jun; 10(3):186-194. PMID: [31978591](//www.ncbi.nlm.nih.gov/pubmed/31978591).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31978591/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:HumansCTClinical Trials

  19. Quinn TJ, **Hamstra D**. Hypofractionation in Prostate Cancer Using Proton Beam. Int J Radiat Oncol Biol Phys. 2019 11 15; 105(4):723-726. PMID: [31655657](//www.ncbi.nlm.nih.gov/pubmed/31655657).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31655657/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  20. **Hamstra DA** , Pugh SL, Lepor H, Rosenthal SA, Pienta KJ, Gomella L, Peters C, D'Souza DP, Zeitzer KL, Jones CU, Hall WA, Horwitz E, Pisansky TM, Souhami L, Hartford AC, Dominello M, Feng F, Sandler HM. Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902. Radiother Oncol. 2019 12; 141:137-143. PMID: [31540746](//www.ncbi.nlm.nih.gov/pubmed/31540746); PMCID: [PMC6912855](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6912855).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31540746/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:HumansCTClinical Trials

  21. Quinn TJ, Almahariq MF, Siddiqui ZA, Thompson AB, **Hamstra DA** , Kabolizadeh P, Gowans KL, Chen PY. Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis. Pediatr Blood Cancer. 2019 12; 66(12):e27969. PMID: [31464041](//www.ncbi.nlm.nih.gov/pubmed/31464041).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31464041/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansPHPublic Health

  22. Foster B, Jackson W, Foster C, Dess R, Abu-Isa E, McLaughlin PW, Merrick G, Hearn J, Spratt D, Liauw S, **Hamstra D**. Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization. Am J Clin Oncol. 2019 04; 42(4):382-390. PMID: [30724780](//www.ncbi.nlm.nih.gov/pubmed/30724780).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  23. Dignam JJ, **Hamstra DA** , Lepor H, Grignon D, Brereton H, Currey A, Rosenthal S, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Sandler HM. Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202. J Clin Oncol. 2019 01 20; 37(3):213-221. PMID: [30526194](//www.ncbi.nlm.nih.gov/pubmed/30526194); PMCID: [PMC6338393](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6338393).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30526194/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  24. Seymour Z, **Hamstra D**. Quality of life is not compromised with intensification of androgen therapy in recurrent prostate cancer. Lancet Oncol. 2018 10; 19(10):1275-1276. PMID: [30213450](//www.ncbi.nlm.nih.gov/pubmed/30213450).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30213450/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  25. Johnson SB, Hung J, Kapadia N, Oh KS, Kim M, **Hamstra DA**. Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma. Pract Radiat Oncol. 2019 Jan; 9(1):e22-e28. PMID: [30036592](//www.ncbi.nlm.nih.gov/pubmed/30036592).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30036592/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:HumansCTClinical Trials

  26. Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Lau H, Duclos M, Parliament M, Morton G, **Hamstra D** , Seider M, Lock MI, Patel M, Gay H, Vigneault E, Winter K, Sandler H, Bahary JP. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial. JAMA Oncol. 2018 06 14; 4(6):e180039. PMID: [29543933](//www.ncbi.nlm.nih.gov/pubmed/29543933); PMCID: [PMC5885160](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5885160).

Citations:
[82](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29543933/citedby/) Fields:

Neo Neoplasms

Translation:HumansPHPublic Health

  27. **Hamstra DA**. In Regard to Jang et?al. Int J Radiat Oncol Biol Phys. 2018 04 01; 100(5):1292-1293. PMID: [29722666](//www.ncbi.nlm.nih.gov/pubmed/29722666).

Citations:  Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

  28. Litzenberg DW, Muenz DG, Archer PG, Jackson WC, **Hamstra DA** , Hearn JW, Schipper MJ, Spratt DE. Changes in prostate orientation due to removal of a Foley catheter. Med Phys. 2018 Apr; 45(4):1369-1378. PMID: [29474748](//www.ncbi.nlm.nih.gov/pubmed/29474748).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29474748/citedby/) Fields:

Bio BiophysicsPhy PhysicsRad RadiologyRad Radiotherapy

Translation:Humans

  29. **Hamstra DA** , Lee KC, Eisbruch A, Sunkara P, Borgonha S, Phillip B, Campbell KCM, Ross BD, Rehemtulla A. Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer. Head Neck. 2018 07; 40(7):1375-1388. PMID: [29473247](//www.ncbi.nlm.nih.gov/pubmed/29473247).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29473247/citedby/) Fields:

Gen General SurgeryNeo Neoplasms

Translation:HumansCTClinical Trials

  30. Dess RT, Devasia TP, Aghdam N, Jackson WC, Soni PD, Smith CP, Mitchell AL, Suy S, **Hamstra DA** , Jolly S, Nguyen PL, Feng FY, Schipper MJ, Skolarus TA, Miller DC, Wittmann DA, Collins SP, Spratt DE. Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):376-386. PMID: [29487023](//www.ncbi.nlm.nih.gov/pubmed/29487023).

Citations:  Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  31. **Hamstra DA** , Feng FY, Spratt DE, Moraes FY, Leite ETT, Arruda FF, Gadia R, Abreu CECV, Marta GN, Hanna SA, Silva JLFD, Carvalho HA. Self-reported Conflicts of Interest and Trial Sponsorship of Clinical Trials in Prostate Cancer Involving Radiotherapy. Am J Clin Oncol. 2018 Jan; 41(1):6-12. PMID: [26703812](//www.ncbi.nlm.nih.gov/pubmed/26703812).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26703812/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  32. Karsh LI, Gross ET, Pieczonka CM, Aliotta PJ, Skomra CJ, Ponsky LE, Nieh PT, Han M, **Hamstra DA** , Shore ND. Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data. Urology. 2018 May; 115:39-44. PMID: [29174940](//www.ncbi.nlm.nih.gov/pubmed/29174940).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29174940/citedby/) Fields:

Uro Urology

Translation:Humans

  33. Masi K, Archer P, Jackson W, Sun Y, Schipper M, **Hamstra D** , Matuszak M. Knowledge-based treatment planning and its potential role in the transition between treatment planning systems. Med Dosim. 2018 Autumn; 43(3):251-257. PMID: [29174796](//www.ncbi.nlm.nih.gov/pubmed/29174796).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29174796/citedby/) Fields:

Rad Radiotherapy

Translation:Humans

  34. Yu JB, **Hamstra D**. Point: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? Quality of Life is Better After Modern Radiotherapy Compared With Surgery. Oncology (Williston Park). 2017 11 15; 31(11):830-2, 835. PMID: [29179251](//www.ncbi.nlm.nih.gov/pubmed/29179251).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  35. **Hamstra DA** , de Kloet ER, de Rover M, Van der Does W. Oral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study. J Psychosom Res. 2017 12; 103:119-126. PMID: [29167038](//www.ncbi.nlm.nih.gov/pubmed/29167038).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29167038/citedby/) Fields:

Psy Psychiatry

Translation:Humans

  36. Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, **Hamstra DA** , Schipper MJ, Collins SP, Spratt DE. Erectile function after stereotactic body radiotherapy for localized prostate cancer. BJU Int. 2018 01; 121(1):61-68. PMID: [28710895](//www.ncbi.nlm.nih.gov/pubmed/28710895).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28710895/citedby/) Fields:

Uro Urology

Translation:Humans

  37. Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE, Spratt DE, **Hamstra DA**. A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Pract Radiat Oncol. 2018 Jan - Feb; 8(1):40-47. PMID: [29304991](//www.ncbi.nlm.nih.gov/pubmed/29304991).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29304991/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:HumansCTClinical Trials

  38. **Hamstra DA**. Don't Bet Against the Elderly. Int J Radiat Oncol Biol Phys. 2017 09 01; 99(1):7. PMID: [28816163](//www.ncbi.nlm.nih.gov/pubmed/28816163).

Citations:  Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  39. **Hamstra DA** , Feng FY, Liauw SL, Son CH. High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir =0.2 to Select Men for Short-term Hormonal Therapy. Am J Clin Oncol. 2017 Aug; 40(4):348-352. PMID: [25436827](//www.ncbi.nlm.nih.gov/pubmed/25436827).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25436827/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  40. **Hamstra DA** , Mariados N, Sylvester J, Shah D, Gross E, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, Daignault-Newton S, Fischer-Valuck BW, Chundury A, Gay HA, Bosch W, Michalski J. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial. Pract Radiat Oncol. 2018 Jan - Feb; 8(1):e7-e15. PMID: [28951089](//www.ncbi.nlm.nih.gov/pubmed/28951089).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28951089/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:HumansCTClinical Trials

  41. **Hamstra DA** , Krauss D, Buyyounouski MK. In Regard to Morris et?al. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):481-482. PMID: [28463168](//www.ncbi.nlm.nih.gov/pubmed/28463168).

Citations:  Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

  42. Jackson WC, Desai NB, Abugharib AE, Tumati V, Dess RT, Lee JY, Zhao SG, Soliman M, Folkert M, Laine A, Hannan R, Zumsteg ZS, Sandler H, **Hamstra DA** , Montgomery JS, Miller DC, Kozminski MA, Hollenbeck BK, Hearn JW, Palapattu G, Tomlins SA, Mehra R, Morgan TM, Feng FY, Spratt DE. Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study. BJU Int. 2017 09; 120(3):351-357. PMID: [28139024](//www.ncbi.nlm.nih.gov/pubmed/28139024).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28139024/citedby/) Fields:

Uro Urology

Translation:Humans

  43. Gay HA, Sanda MG, Liu J, Wu N, **Hamstra DA** , Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, [Kuban DA](https://profiles.viictr.org/profile/12583748), Hembroff L, Regan MM, Chang P, Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment Consortium, Michalski JM. External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):304-317. PMID: [28463150](//www.ncbi.nlm.nih.gov/pubmed/28463150); PMCID: [PMC5493021](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5493021).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28463150/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  44. **Hamstra DA** , Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, Daignault-Newton S, Fischer-Valuck BW, Chundury A, Gay H, Bosch W, Michalski J. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of?a?Phase III Trial. Int J Radiat Oncol Biol Phys. 2017 04 01; 97(5):976-985. PMID: [28209443](//www.ncbi.nlm.nih.gov/pubmed/28209443).

Citations:
[106](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28209443/citedby/)
Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansPHPublic HealthCTClinical Trials

  45. Dess RT, Jackson WC, Suy S, Soni PD, Lee JY, Abugharib AE, Zumsteg ZS, Feng FY, **Hamstra DA** , Collins SP, Spratt DE. Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer. Cancer. 2017 05 01; 123(9):1635-1642. PMID: [28001303](//www.ncbi.nlm.nih.gov/pubmed/28001303).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28001303/citedby/) Fields:

Neo Neoplasms

Translation:HumansPHPublic Health

  46. **Hamstra DA** , de Kloet ER, Quataert I, Jansen M, Van der Does W. Mineralocorticoid receptor haplotype, estradiol, progesterone and emotional information processing. Psychoneuroendocrinology. 2017 02; 76:162-173. PMID: [27936434](//www.ncbi.nlm.nih.gov/pubmed/27936434).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27936434/citedby/) Fields:

End EndocrinologyNeu NeurologyPsy Psychiatry

Translation:Humans

  47. Upadhyaya SA, Koschmann C, Muraszko K, Venneti S, Garton HJ, **Hamstra DA** , Maher CO, Betz BL, Brown NA, Wahl D, Weigelin HC, DuRoss KE, Leonard AS, Robertson PL. Brainstem Low-Grade Gliomas in Children-Excellent Outcomes With Multimodality Therapy. J Child Neurol. 2017 02; 32(2):194-203. PMID: [27810966](//www.ncbi.nlm.nih.gov/pubmed/27810966); PMCID: [PMC5582383](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5582383).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27810966/citedby/) Fields:

Neu NeurologyPed Pediatrics

Translation:Humans

  48. Tendulkar RD, Agrawal S, Gao T, Efstathiou JA, Pisansky TM, Michalski JM, Koontz BF, **Hamstra DA** , Feng FY, Liauw SL, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy. J Clin Oncol. 2016 Oct 20; 34(30):3648-3654. PMID: [27528718](//www.ncbi.nlm.nih.gov/pubmed/27528718).

Citations:
[93](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27528718/citedby/) Fields:

Neo Neoplasms

  49. Caffo O, Thompson C, De Santis M, Kragelj B, **Hamstra DA** , Fellin G, Pappagallo GL, Galligioni E, Choudhury A, Azria D. Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trials. Radiother Oncol. 2016 11; 121(2):193-198. PMID: [27720221](//www.ncbi.nlm.nih.gov/pubmed/27720221).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27720221/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  50. Pisansky TM, Agrawal S, **Hamstra DA** , Koontz BF, Liauw SL, Efstathiou JA, Michalski JM, Feng FY, Abramowitz MC, Pollack A, Anscher MS, Moghanaki D, Den RB, Stephans KL, Zietman AL, Lee WR, Kattan MW, Stephenson AJ, Tendulkar RD. Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational Study. Int J Radiat Oncol Biol Phys. 2016 12 01; 96(5):1046-1053. PMID: [27745980](//www.ncbi.nlm.nih.gov/pubmed/27745980).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27745980/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  51. Chang P, Regan MM, Patil D, Wei JT, Hembroff LA, Michalski JM, Saigal CS, Litwin MS, **Hamstra DA** , Kaplan ID, Ciezki JP, Klein EA, Kibel AS, Sandler HM, Dunn RL, Crociani CM, Sanda MG, PROST-QA Consortium, Ferrer M, Guedea F. Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment. J Urol. 2017 02; 197(2):376-384. PMID: [27593476](//www.ncbi.nlm.nih.gov/pubmed/27593476); PMCID: [PMC5501938](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5501938).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27593476/citedby/) Fields:

Uro Urology

Translation:Humans

  52. Lee JY, Daignault-Newton S, Heath G, Scarlett S, Sanda MG, Chang P, Regan MM, Michalski JM, Sandler HM, Feng FY, [Kuban DA](https://profiles.viictr.org/profile/12583748), Zietman AL, Ciezki JP, Kaplan ID, Crociani C, McLaughlin WP, Mantz CA, Finkelstein SE, Suy S, Collins SP, **Hamstra DA** , Spratt DE, Garin O, Ferrer M. Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):770-777. PMID: [27663760](//www.ncbi.nlm.nih.gov/pubmed/27663760).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27663760/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  53. Mak RH, Hunt D, Efstathiou JA, Heney NM, Jones CU, Lukka HR, Patel M, Balogh A, Leibenhaut MH, **Hamstra DA** , Roof KS, Jeffrey Lee R, Gore EM, Sandler HM, Shipley WU, Bahary JP, Nabid A. Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01. Urol Oncol. 2016 10; 34(10):430.e1-7. PMID: [27381895](//www.ncbi.nlm.nih.gov/pubmed/27381895); PMCID: [PMC5035191](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5035191).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27381895/citedby/) Fields:

Neo NeoplasmsUro Urology

Translation:HumansPHPublic HealthCTClinical Trials

  54. **Hamstra DA** , de Kloet ER, Tollenaar M, Verkuil B, Manai M, Putman P, Van der Does W. Mineralocorticoid receptor haplotype moderates the effects of oral contraceptives and menstrual cycle on emotional information processing. J Psychopharmacol. 2016 10; 30(10):1054-61. PMID: [27222270](//www.ncbi.nlm.nih.gov/pubmed/27222270).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27222270/citedby/) Fields:

Psy Psychopharmacology

Translation:Humans

  55. Feng FY, Zhang Y, Kothari V, Evans JR, Jackson WC, Chen W, Johnson SB, Luczak C, Wang S, **Hamstra DA**. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner. Neoplasia. 2016 04; 18(4):213-22. PMID: [27108384](//www.ncbi.nlm.nih.gov/pubmed/27108384); PMCID: [PMC4840291](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4840291).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27108384/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  56. McLaughlin PW, Merrick GS, Vainshtein JM, **Hamstra DA** , Shilkrut M. Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy. Am J Clin Oncol. 2016 Apr; 39(2):181-8. PMID: [24517957](//www.ncbi.nlm.nih.gov/pubmed/24517957).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24517957/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  57. Schipper M, Vance S, Feng FY, Olson KB, **Hamstra DA** , Vainshtein JM. Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy. Am J Clin Oncol. 2016 Apr; 39(2):173-80. PMID: [24487421](//www.ncbi.nlm.nih.gov/pubmed/24487421).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24487421/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  58. Jackson WC, Feng FY, Daignault S, Hussain M, Smith D, Cooney K, Pienta K, Jolly S, Hollenbeck B, Olson KB, Sandler HM, Ray ME, **Hamstra DA**. A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy. Adv Radiat Oncol. 2016 Jan-Mar; 1(1):59-66. PMID: [28799570](//www.ncbi.nlm.nih.gov/pubmed/28799570); PMCID: [PMC5506748](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5506748).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28799570/citedby/)

  59. Bernat JK, Wittman DA, Hawley ST, **Hamstra DA** , Helfand AM, Haggstrom DA, Darwish-Yassine M, Skolarus TA. Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care. BJU Int. 2016 09; 118(3):372-8. PMID: [26389529](//www.ncbi.nlm.nih.gov/pubmed/26389529); PMCID: [PMC4835263](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4835263).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26389529/citedby/) Fields:

Uro Urology

Translation:Humans

  60. Magers MJ, Zhan T, Udager AM, Wei JT, Tomlins SA, Wu AJ, Kunju LP, Lew M, Feng FY, **Hamstra DA** , Siddiqui J, Chinnaiyan AM, Montgomery JS, Weizer AZ, Morgan TM, Hollenbeck BK, Miller DC, Palapattu GS, Jiang H, Mehra R. Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology. Med Oncol. 2015 Nov; 32(11):249. PMID: [26442515](//www.ncbi.nlm.nih.gov/pubmed/26442515).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  61. Johnson SB, Jackson WC, Murgic J, Feng FY, **Hamstra DA**. Time to Nadir PSA: Of Popes and PSA--The Immortality Bias. Am J Clin Oncol. 2015 Oct; 38(5):465-71. PMID: [24064749](//www.ncbi.nlm.nih.gov/pubmed/24064749).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24064749/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  62. Evans JR, Zhao S, Daignault S, Sanda MG, Michalski J, Sandler HM, [Kuban DA](https://profiles.viictr.org/profile/12583748), Ciezki J, Kaplan ID, Zietman AL, Hembroff L, Feng FY, Suy S, Skolarus TA, McLaughlin PW, Wei JT, Dunn RL, Finkelstein SE, Mantz CA, Collins SP, **Hamstra DA** , PROSTQA Study Consortium. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Radiother Oncol. 2015 Aug; 116(2):179-84. PMID: [26276528](//www.ncbi.nlm.nih.gov/pubmed/26276528).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26276528/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  63. Mariados N, **Hamstra DA**. In Reply to King et al. Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93(4):937-9. PMID: [26530768](//www.ncbi.nlm.nih.gov/pubmed/26530768).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26530768/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansPHPublic Health

  64. Jackson WC, Johnson SB, Feng FY, **Hamstra DA**. Salvage radiation therapy improves metastasis-free survival for clinically aggressive and indolent prostate cancer recurrences after radical prostatectomy. Am J Clin Oncol. 2015 Aug; 38(4):367-72. PMID: [23822986](//www.ncbi.nlm.nih.gov/pubmed/23822986).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23822986/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  65. Shumway DA, **Hamstra DA**. Reply to G. Gandaglia et al and K. Lu. J Clin Oncol. 2015 Sep 01; 33(25):2833-4. PMID: [26215955](//www.ncbi.nlm.nih.gov/pubmed/26215955).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  66. Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, **Hamstra DA** , Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, [Kuban DA](https://profiles.viictr.org/profile/12583748), Moughan J, Sandler H. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):294-302. PMID: [26209502](//www.ncbi.nlm.nih.gov/pubmed/26209502); PMCID: [PMC4719152](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4719152).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26209502/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansCTClinical Trials

  67. Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, **Hamstra DA** , Feng FY. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol. 2016 Jan; 69(1):50-7. PMID: [26004800](//www.ncbi.nlm.nih.gov/pubmed/26004800).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26004800/citedby/) Fields:

Uro Urology

Translation:Humans

  68. Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, **Hamstra DA** , Bosch W, Gay H, Michalski J. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric?and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate?Image Guided Intensity Modulated Radiation?Therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):971-977. PMID: [26054865](//www.ncbi.nlm.nih.gov/pubmed/26054865).

Citations:
[106](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26054865/citedby/)
Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansPHPublic Health

  69. Liss AL, Abu-Isa EI, Jawad MS, Feng FY, Vance SM, Winfield RJ, Narayana V, Sandler HM, McLaughlin PW, **Hamstra DA**. Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5. Brachytherapy. 2015 Jul-Aug; 14(4):502-10. PMID: [25911994](//www.ncbi.nlm.nih.gov/pubmed/25911994).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25911994/citedby/) Fields:

Rad Radiotherapy

Translation:Humans

  70. Koloff ZB, **Hamstra DA** , Wei JT, Montgomery JS, Tomlins SA, Wu AJ, Morgan TM, Siddiqui J, Paich K, Chinnaiyan AM, Feng FY, Weizer AZ, Kunju LP, Hollenbeck BK, Miller DC, Palapattu GS, Mehra R. Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series. Asian J Urol. 2015 Jan; 2(1):53-58. PMID: [29264120](//www.ncbi.nlm.nih.gov/pubmed/29264120); PMCID: [PMC5730694](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5730694).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29264120/citedby/)

  71. Walston S, **Hamstra DA** , Oh K, Woods G, Guiou M, Olshefski RS, Chakravarti A, Williams TM. A multi-institutional experience in pediatric high-grade glioma. Front Oncol. 2015; 5:28. PMID: [25741472](//www.ncbi.nlm.nih.gov/pubmed/25741472); PMCID: [PMC4332307](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4332307).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25741472/citedby/)

  72. Shumway DA, **Hamstra DA**. Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence? J Clin Oncol. 2015 Mar 01; 33(7):676-8. PMID: [25559801](//www.ncbi.nlm.nih.gov/pubmed/25559801).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25559801/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  73. Foster CC, Jackson WC, Foster BC, Johnson SB, Feng FY, **Hamstra DA**. Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapy. Radiat Oncol. 2014 Nov 26; 9:245. PMID: [25424123](//www.ncbi.nlm.nih.gov/pubmed/25424123); PMCID: [PMC4255426](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4255426).

Citations:  Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  74. **Hamstra DA** , Bae K, Hanks G, Hu C, Shipley WU, Pan CC, Roach M, Lawton CA, Sandler HM. Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413. Cancer. 2015 Mar 15; 121(6):844-52. PMID: [25410885](//www.ncbi.nlm.nih.gov/pubmed/25410885); PMCID: [PMC4657945](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4657945).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25410885/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  75. **Hamstra DA**. From the guest editor: Proton therapy: current evidence, challenges, and future plans. Cancer J. 2014 Nov-Dec; 20(6):369-70. PMID: [25415680](//www.ncbi.nlm.nih.gov/pubmed/25415680).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25415680/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  76. **Hamstra DA** , Johnson SB, Daignault S, Zikmund-Fisher BJ, Taylor JM, Larkin K, Wood A, Fagerlin A. The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy. Med Decis Making. 2015 01; 35(1):27-36. PMID: [25277673](//www.ncbi.nlm.nih.gov/pubmed/25277673); PMCID: [PMC4567273](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4567273).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25277673/citedby/) Fields:

Hea Health Services ResearchMed Medical Informatics

Translation:Humans

  77. Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, Blute M, Catto J, Chen RC, D'Amico AV, Fitzpatrick JM, [Frank SJ](https://profiles.viictr.org/profile/12582619), Frydenberg M, Glaser A, Graefen M, **Hamstra D** , Kibel A, Mendenhall N, Moretti K, Ramon J, Roos I, Sandler H, Sullivan FJ, Swanson D, Tewari A, Vickers A, Wiegel T, Huland H, Feick G, Froehner M. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. 2015 Mar; 67(3):460-7. PMID: [25234359](//www.ncbi.nlm.nih.gov/pubmed/25234359).

Citations:
[63](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25234359/citedby/) Fields:

Uro Urology

Translation:HumansPHPublic Health

  78. **Hamstra DA** , De Rover M, De Rijk RH, Van der Does W. Oral contraceptives may alter the detection of emotions in facial expressions. Eur Neuropsychopharmacol. 2014 Nov; 24(11):1855-9. PMID: [25224104](//www.ncbi.nlm.nih.gov/pubmed/25224104).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25224104/citedby/) Fields:

Psy Psychopharmacology

Translation:Humans

  79. Chen RC, **Hamstra DA** , Sandler HM, Zietman AL. Complications of prostate cancer treatment. Lancet Oncol. 2014 Apr; 15(4):e150. PMID: [24694635](//www.ncbi.nlm.nih.gov/pubmed/24694635).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24694635/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  80. Hanauer DA, Choi SW, Jong N, **Hamstra DA** , Li Y, Farley FA, Caird MS, King EA. Osteochondromas after radiation for pediatric malignancies: a role for expanded counseling for skeletal side effects. J Pediatr Orthop. 2014 Apr-May; 34(3):331-5. PMID: [23965908](//www.ncbi.nlm.nih.gov/pubmed/23965908); PMCID: [PMC3930617](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3930617).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23965908/citedby/) Fields:

Ort OrthopedicsPed Pediatrics

Translation:Humans

  81. Johnson S, Jackson W, Speers C, Feng F, **Hamstra D**. A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):422-9. PMID: [25407865](//www.ncbi.nlm.nih.gov/pubmed/25407865).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25407865/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  82. **Hamstra DA** , Chen RC. RE: Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. J Natl Cancer Inst. 2014 Mar; 106(3):djt463. PMID: [24586102](//www.ncbi.nlm.nih.gov/pubmed/24586102).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  83. Shilkrut M, Wu A, Thomas DG, **Hamstra DA**. Expression of ribonucleoside reductase subunit M1, but not excision repair cross-complementation group 1, is predictive in muscle-invasive bladder cancer treated with chemotherapy and radiation. Mol Clin Oncol. 2014 May; 2(3):479-487. PMID: [24772321](//www.ncbi.nlm.nih.gov/pubmed/24772321); PMCID: [PMC3999124](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3999124).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24772321/citedby/)

  84. Stenmark MH, Conlon AS, Johnson S, Daignault S, Litzenberg D, Marsh R, Ritter T, Vance S, Kazzi N, Feng FY, Sandler H, Sanda MG, **Hamstra DA**. Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer. Radiother Oncol. 2014 Feb; 110(2):291-7. PMID: [24507766](//www.ncbi.nlm.nih.gov/pubmed/24507766).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24507766/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:HumansPHPublic HealthCTClinical Trials

  85. Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, Mendenhall WM, Williams CR, Regan MM, Chipman JJ, Crociani CM, Sandler HM, Sanda MG, **Hamstra DA**. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer. 2014 Apr 01; 120(7):1076-82. PMID: [24382757](//www.ncbi.nlm.nih.gov/pubmed/24382757); PMCID: [PMC4103169](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4103169).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24382757/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  86. **Hamstra DA**. Oncology scan--intermittent androgen deprivation and the randomized evidence. Int J Radiat Oncol Biol Phys. 2013 Nov 01; 87(3):446-8. PMID: [24075270](//www.ncbi.nlm.nih.gov/pubmed/24075270).

Citations:  Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

  87. Gay HA, Michalski JM, **Hamstra DA** , Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal C, Litwin M, [Kuban D](https://profiles.viictr.org/profile/12583748), Hembroff L, Chang P, Sanda MG, PROSTQA Consortium. Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology. 2013 Dec; 82(6):1363-8. PMID: [24139340](//www.ncbi.nlm.nih.gov/pubmed/24139340); PMCID: [PMC3904352](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3904352).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24139340/citedby/) Fields:

Uro Urology

Translation:Humans

  88. Lao CD, Friedman J, Tsien CI, Normolle DP, Chapman C, Cao Y, Lee O, Schipper M, Van Poznak C, **Hamstra D** , Lawrence T, Hayman J, Redman BG. Concurrent whole brain radiotherapy and bortezomib for brain metastasis. Radiat Oncol. 2013 Aug 21; 8:204. PMID: [23965287](//www.ncbi.nlm.nih.gov/pubmed/23965287); PMCID: [PMC3765365](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3765365).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23965287/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:HumansCTClinical Trials

  89. Litzenberg DW, Gallagher I, Masi KJ, Lee C, Prisciandaro JI, **Hamstra DA** , Ritter T, Lam KL. A measurement technique to determine the calibration accuracy of an electromagnetic tracking system to radiation isocenter. Med Phys. 2013 Aug; 40(8):081711. PMID: [23927308](//www.ncbi.nlm.nih.gov/pubmed/23927308).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23927308/citedby/) Fields:

Bio BiophysicsPhy PhysicsRad RadiologyRad Radiotherapy

  90. Johnson SB, **Hamstra DA** , Jackson WC, Zhou J, Foster B, Foster C, Song Y, Li D, Palapattu GS, Kunju L, Mehra R, Sandler H, Feng FY. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 01; 87(2):275-81. PMID: [23886418](//www.ncbi.nlm.nih.gov/pubmed/23886418).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23886418/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  91. Jackson WC, Johnson SB, Foster B, Foster C, Li D, Song Y, Vainshtein J, Zhou J, **Hamstra DA** , Feng FY. Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):99-107. PMID: [24890350](//www.ncbi.nlm.nih.gov/pubmed/24890350).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24890350/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  92. Jackson WC, Johnson SB, Li D, Foster C, Foster B, Song Y, Schipper M, Shilkrut M, Sandler HM, Morgan TM, Palapattu GS, **Hamstra DA** , Feng FY. A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy. Radiat Oncol. 2013 Jul 08; 8:170. PMID: [23835115](//www.ncbi.nlm.nih.gov/pubmed/23835115); PMCID: [PMC3718717](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3718717).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23835115/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  93. Jackson W, **Hamstra DA** , Johnson S, Zhou J, Foster B, Foster C, Li D, Song Y, Palapattu GS, Kunju LP, Mehra R, Feng FY. Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy. Cancer. 2013 Sep 15; 119(18):3287-94. PMID: [23821578](//www.ncbi.nlm.nih.gov/pubmed/23821578).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23821578/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  94. Shilkrut M, McLaughlin PW, Merrick GS, Vainshtein JM, Feng FY, **Hamstra DA**. Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):721-8. PMID: [23664325](//www.ncbi.nlm.nih.gov/pubmed/23664325).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23664325/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  95. **Hamstra DA** , Conlon AS, Daignault S, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, [Kuban DA](https://profiles.viictr.org/profile/12583748), Wei JT, Sanda MG, Michalski JM, PROSTQA Consortium Study Group. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. Int J Radiat Oncol Biol Phys. 2013 Jul 01; 86(3):546-53. PMID: [23561651](//www.ncbi.nlm.nih.gov/pubmed/23561651).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23561651/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  96. Johnson S, Jackson W, Li D, Song Y, Foster C, Foster B, Zhou J, Vainshtein J, Feng F, **Hamstra D**. The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Jul 01; 86(3):554-61. PMID: [23561650](//www.ncbi.nlm.nih.gov/pubmed/23561650).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23561650/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  97. Feng FY, Blas K, Olson K, Stenmark M, Sandler H, **Hamstra DA**. Retrospective evaluation reveals that long-term androgen deprivation therapy improves cause-specific and overall survival in the setting of dose-escalated radiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):64-71. PMID: [23462420](//www.ncbi.nlm.nih.gov/pubmed/23462420).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23462420/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  98. Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, **Hamstra DA** , Shipley WU, [Hahn SM](https://profiles.viictr.org/profile/17440133), Zietman AL, Bekelman JE, Efstathiou JA. Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer. 2013 May 01; 119(9):1729-35. PMID: [23436283](//www.ncbi.nlm.nih.gov/pubmed/23436283); PMCID: [PMC3759976](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3759976).

Citations:
[37](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23436283/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  99. **Hamstra DA** , Stenmark MH, Ritter T, Litzenberg D, Jackson W, Johnson S, Albrecht-Unger L, Donaghy A, Phelps L, Blas K, Halverson S, Marsh R, Olson K, Feng FY. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Apr 01; 85(5):1246-53. PMID: [23265567](//www.ncbi.nlm.nih.gov/pubmed/23265567).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23265567/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansPHPublic Health

  100. Stenmark MH, **Hamstra DA**. Re: Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era: A. S. Kibel, J. P. Ciezki, E. A. Klein, C. A. Reddy, J. D. Lubahn, J. Haslag-minoff, J. O. Deasy, J. M. Michalski, D. Kallogjeri, J. F. Piccirillo, D. M. Rabah, C. Yu, M. W. Kattan And A. J. Stephenson; J Urol 2012; 187: 1259-1265. J Urol. 2012 Dec; 188(6):2438-9; author reply 2439-40. PMID: [23088984](//www.ncbi.nlm.nih.gov/pubmed/23088984).

Citations:  Fields:

Uro Urology

Translation:Humans

  101. Shilkrut M, Feng F, **Hamstra DA**. General commentary to the "management of biochemical recurrence after primary localized therapy for prostate cancer" by darwish o. M. And raj g. V. Front Oncol. 2012; 2:126. PMID: [23061043](//www.ncbi.nlm.nih.gov/pubmed/23061043); PMCID: [PMC3459002](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3459002).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23061043/citedby/)

  102. Shilkrut M, Merrick GS, McLaughlin PW, Stenmark MH, Abu-Isa E, Vance SM, Sandler HM, Feng FY, **Hamstra DA**. The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer. Cancer. 2013 Feb 01; 119(3):681-90. PMID: [22893254](//www.ncbi.nlm.nih.gov/pubmed/22893254).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22893254/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  103. Murgic J, Stenmark MH, Halverson S, Blas K, Feng FY, **Hamstra DA**. The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer. Radiat Oncol. 2012 Aug 01; 7:127. PMID: [22852797](//www.ncbi.nlm.nih.gov/pubmed/22852797); PMCID: [PMC3484035](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3484035).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22852797/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  104. Vainshtein J, Abu-Isa E, Olson KB, Ray ME, Sandler HM, Normolle D, Litzenberg DW, Masi K, Pan C, **Hamstra DA**. Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiat Oncol. 2012 Jun 09; 7:82. PMID: [22681643](//www.ncbi.nlm.nih.gov/pubmed/22681643); PMCID: [PMC3408353](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3408353).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22681643/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:HumansCTClinical Trials

  105. Amro H, **Hamstra DA** , Mcshan DL, Sandler H, Vineberg K, Hadley S, Litzenberg D. The dosimetric impact of prostate rotations during electromagnetically guided external-beam radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):230-6. PMID: [22554583](//www.ncbi.nlm.nih.gov/pubmed/22554583); PMCID: [PMC3413775](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3413775).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22554583/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  106. Stenmark MH, Vineberg K, Ten Haken RK, **Hamstra DA** , Feng M. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Med Dosim. 2012; 37(3):240-4. PMID: [22189029](//www.ncbi.nlm.nih.gov/pubmed/22189029).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22189029/citedby/) Fields:

Rad Radiotherapy

Translation:Humans

  107. Vance SM, Stenmark MH, Blas K, Halverson S, **Hamstra DA** , Feng FY. Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):940-6. PMID: [22056069](//www.ncbi.nlm.nih.gov/pubmed/22056069).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22056069/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  108. Wu J, Johnson TD, Chenevert TL, Meyer CR, Rehemtulla A, **Hamstra DA** , Ross BD, Galb?n CJ. Predicting treatment efficacy via quantitative magnetic resonance imaging: a Bayesian joint model. J R Stat Soc Ser C Appl Stat. 2012 01 01; 61(1):83-98. PMID: [22577240](//www.ncbi.nlm.nih.gov/pubmed/22577240); PMCID: [PMC3346284](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3346284).

Citations:

  109. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, **Hamstra DA** , [Pisters LL](https://profiles.viictr.org/profile/12582535), [Kuban DA](https://profiles.viictr.org/profile/12583748), Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14. PMID: [21934053](//www.ncbi.nlm.nih.gov/pubmed/21934053); PMCID: [PMC3831607](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3831607).

Citations:
[86](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21934053/citedby/) Fields:

Med Medicine (General)

Translation:HumansPHPublic Health

  110. Kapadia NS, Olson K, Sandler HM, Feng FY, **Hamstra DA**. Interval to biochemical failure as a biomarker for cause-specific and overall survival after dose-escalated external beam radiation therapy for prostate cancer. Cancer. 2012 Apr 15; 118(8):2059-68. PMID: [22009287](//www.ncbi.nlm.nih.gov/pubmed/22009287).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22009287/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  111. Feng FY, Qian Y, Stenmark MH, Halverson S, Blas K, Vance S, Sandler HM, **Hamstra DA**. Perineural invasion predicts increased recurrence, metastasis, and death from prostate cancer following treatment with dose-escalated radiation therapy. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e361-7. PMID: [21820250](//www.ncbi.nlm.nih.gov/pubmed/21820250).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21820250/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  112. Litzenberg DW, Balter JM, Hadley SW, **Hamstra DA** , Willoughby TR, Kupelian PA, Djemil T, Mahadevan A, Jani S, Weinstein G, Solberg T, Enke C, Levine L, Sandler HM. Prostate intrafraction translation margins for real-time monitoring and correction strategies. Prostate Cancer. 2012; 2012:130579. PMID: [22111005](//www.ncbi.nlm.nih.gov/pubmed/22111005); PMCID: [PMC3195290](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3195290).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22111005/citedby/)

  113. Halverson S, Schipper M, Blas K, Lee V, Sabolch A, Olson K, Sandler HM, Feng FY, **Hamstra DA**. The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: evaluation and optimization in patients at higher risk of relapse. Radiother Oncol. 2011 Dec; 101(3):513-20. PMID: [21703711](//www.ncbi.nlm.nih.gov/pubmed/21703711).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21703711/citedby/) Fields:

Neo NeoplasmsRad Radiotherapy

Translation:Humans

  114. Stenmark MH, Blas K, Halverson S, Sandler HM, Feng FY, **Hamstra DA**. Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk disease. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e335-44. PMID: [21645976](//www.ncbi.nlm.nih.gov/pubmed/21645976).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21645976/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  115. Chenevert TL, Meyer CR, Tsien C, Lawrence TS, **Hamstra DA** , Junck L, Sundgren PC, Johnson TD, Sebolt-Leopold JS, Rehemtulla A, Ross BD, Galb?n CJ, Galb?n S. Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res. 2011 Jul 15; 17(14):4751-60. PMID: [21527563](//www.ncbi.nlm.nih.gov/pubmed/21527563); PMCID: [PMC3139775](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3139775).

Citations:
[49](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21527563/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  116. Sabolch A, Feng FY, Daignault-Newton S, Halverson S, Blas K, Phelps L, Olson KB, Sandler HM, **Hamstra DA**. Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e351-60. PMID: [21493015](//www.ncbi.nlm.nih.gov/pubmed/21493015).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21493015/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  117. Oh KS, Hung J, Robertson PL, Garton HJ, Muraszko KM, Sandler HM, **Hamstra DA**. Outcomes of multidisciplinary management in pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e481-8. PMID: [21470783](//www.ncbi.nlm.nih.gov/pubmed/21470783).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21470783/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  118. **Hamstra DA** , Bae K, Pilepich MV, Hanks GE, Grignon DJ, McGowan DG, Roach M, Lawton C, Lee RJ, Sandler H. Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1293-301. PMID: [21458924](//www.ncbi.nlm.nih.gov/pubmed/21458924); PMCID: [PMC4675045](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4675045).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21458924/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  119. Qian Y, Feng FY, Halverson S, Blas K, Sandler HM, **Hamstra DA**. The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):e135-42. PMID: [21345617](//www.ncbi.nlm.nih.gov/pubmed/21345617).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21345617/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:Humans

  120. Raldow A, **Hamstra DA** , Kim SN, Yu JB. Adjuvant radiotherapy after radical prostatectomy: evidence and analysis. Cancer Treat Rev. 2011 Apr; 37(2):89-96. PMID: [20667660](//www.ncbi.nlm.nih.gov/pubmed/20667660).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20667660/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Humans

  121. **Hamstra DA** , Michalski JM, Roach M, Sandler HM. Do not count out external-beam radiation therapy for high-risk prostate cancer. J Clin Oncol. 2010 Oct 01; 28(28):e518-9; author reply e521-e522. PMID: [20660824](//www.ncbi.nlm.nih.gov/pubmed/20660824).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  122. Raldow A, **Hamstra DA** , Kim S, Yu JB. Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park). 2010 Jul; 24(8):692-700, 702. PMID: [20718248](//www.ncbi.nlm.nih.gov/pubmed/20718248).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20718248/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  123. **Hamstra DA** , Eisbruch A, Naidu MU, Ramana GV, Sunkara P, Campbell KC, Ross BD, Rehemtulla A. Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer. Clin Cancer Res. 2010 May 01; 16(9):2666-76. PMID: [20388849](//www.ncbi.nlm.nih.gov/pubmed/20388849).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20388849/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  124. Tsien C, Chenevert TL, Johnson TD, **Hamstra DA** , Sundgren PC, Junck L, Meyer CR, Rehemtulla A, Lawrence T, Ross BD, Galb?n CJ. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol. 2010 May 01; 28(13):2293-9. PMID: [20368564](//www.ncbi.nlm.nih.gov/pubmed/20368564); PMCID: [PMC2860441](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2860441).

Citations:
[84](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20368564/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  125. Mukherji SK, Chenevert TL, Meyer CR, **Hamstra DA** , Bland PH, Johnson TD, Moffat BA, Rehemtulla A, Eisbruch A, Ross BD, Galb?n CJ. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol. 2009 08 18; 2(3):184-90. PMID: [19701503](//www.ncbi.nlm.nih.gov/pubmed/19701503); PMCID: [PMC2730136](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2730136).

Citations:
[56](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19701503/citedby/)

  126. Chenevert TL, Meyer CR, Tsien C, Lawrence TS, **Hamstra DA** , Junck L, Sundgren PC, Johnson TD, Ross DJ, Rehemtulla A, Ross BD, Galb?n CJ. The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med. 2009 May; 15(5):572-6. PMID: [19377487](//www.ncbi.nlm.nih.gov/pubmed/19377487); PMCID: [PMC3307223](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3307223).

Citations:
[97](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19377487/citedby/) Fields:

Med Medicine (General)Mol Molecular Biology

Translation:Humans

  127. Murphy JD, Spalding AC, Somnay YR, Markwart S, Ray ME, **Hamstra DA**. Inhibition of mTOR radiosensitizes soft tissue sarcoma and tumor vasculature. Clin Cancer Res. 2009 Jan 15; 15(2):589-96. PMID: [19147764](//www.ncbi.nlm.nih.gov/pubmed/19147764).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19147764/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  128. **Hamstra DA** , Lee KC, Moffat BA, Chenevert TL, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. Transl Oncol. 2008 Dec; 1(4):187-94. PMID: [19043529](//www.ncbi.nlm.nih.gov/pubmed/19043529); PMCID: [PMC2582167](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2582167).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19043529/citedby/)

  129. Spalding AC, **Hamstra DA**. Radiation therapy reduces local failure and improves overall survival in sPNET. Pediatr Blood Cancer. 2008 Jul; 51(1):148; author reply 149-50. PMID: [18273871](//www.ncbi.nlm.nih.gov/pubmed/18273871).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  130. **Hamstra DA** , Meyer CR, Johnson TD, Sundgren PC, Tsien C, Lawrence TS, Junck L, Ross DJ, Rehemtulla A, Ross BD, Chenevert TL, Galb?n CJ. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol. 2008 Jul 10; 26(20):3387-94. PMID: [18541899](//www.ncbi.nlm.nih.gov/pubmed/18541899); PMCID: [PMC3266717](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3266717).

Citations:
[133](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18541899/citedby/)
Fields:

Neo Neoplasms

Translation:Humans

  131. Vuyyuri SB, **Hamstra DA** , Khanna D, Hamilton CA, Markwart SM, Campbell KC, Sunkara P, Ross BD, Rehemtulla A. Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis. Clin Cancer Res. 2008 Apr 01; 14(7):2161-70. PMID: [18381958](//www.ncbi.nlm.nih.gov/pubmed/18381958).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18381958/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  132. Murphy JD, Lucas DR, Somnay YR, **Hamstra DA** , Ray ME. Gemcitabine-mediated radiosensitization of human soft tissue sarcoma. Transl Oncol. 2008 Mar; 1(1):50-6. PMID: [18607508](//www.ncbi.nlm.nih.gov/pubmed/18607508); PMCID: [PMC2510764](//www.ncbi.nlm.nih.gov/pmc/articles/PMC2510764).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18607508/citedby/)

  133. Contessa JN, **Hamstra DA**. Revoking the privilege: targeting HER2 in the central nervous system. Mol Pharmacol. 2008 Feb; 73(2):271-3. PMID: [17981994](//www.ncbi.nlm.nih.gov/pubmed/17981994).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17981994/citedby/) Fields:

Mol Molecular BiologyPha Pharmacology

Translation:HumansAnimals

  134. **Hamstra DA** , Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol. 2007 Sep 10; 25(26):4104-9. PMID: [17827460](//www.ncbi.nlm.nih.gov/pubmed/17827460).

Citations:
[120](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17827460/citedby/)
Fields:

Neo Neoplasms

Translation:HumansAnimals

  135. **Hamstra DA**. Primary radiotherapy for childhood ependymoma? Lancet Oncol. 2007 Sep; 8(9):758-9; author reply 760-1. PMID: [17765188](//www.ncbi.nlm.nih.gov/pubmed/17765188).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17765188/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  136. Lee KC, **Hamstra DA** , Bhojani MS, Khan AP, Ross BD, Rehemtulla A. Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy. Clin Cancer Res. 2007 Mar 15; 13(6):1839-46. PMID: [17363540](//www.ncbi.nlm.nih.gov/pubmed/17363540).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17363540/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  137. Cao Y, Nagesh V, **Hamstra D** , Tsien CI, Ross BD, Chenevert TL, Junck L, Lawrence TS. The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res. 2006 Sep 01; 66(17):8912-7. PMID: [16951209](//www.ncbi.nlm.nih.gov/pubmed/16951209).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16951209/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  138. **Hamstra DA** , Bhojani MS, Griffin LB, Laxman B, Ross BD, Rehemtulla A. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res. 2006 Aug 01; 66(15):7482-9. PMID: [16885345](//www.ncbi.nlm.nih.gov/pubmed/16885345).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16885345/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  139. Bhojani MS, **Hamstra DA** , Chang DC, Coppola JM, Khan AP, Reddy GR, Ross BD, Rehemtulla A. Imaging of proteolytic activity using a conditional cell surface receptor. Mol Imaging. 2006 Apr-Jun; 5(2):129-37. PMID: [16954027](//www.ncbi.nlm.nih.gov/pubmed/16954027).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16954027/citedby/) Fields:

Dia Diagnostic Imaging

Translation:HumansAnimalsCells

  140. Moffat BA, Chen M, Kariaapper MS, **Hamstra DA** , Hall DE, Stojanovska J, Johnson TD, Blaivas M, Kumar M, Chenevert TL, Rehemtulla A, Ross BD. Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D. Clin Cancer Res. 2006 Mar 01; 12(5):1525-32. PMID: [16533777](//www.ncbi.nlm.nih.gov/pubmed/16533777).

Citations:
[15](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16533777/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  141. **Hamstra DA** , Chenevert TL, Moffat BA, Johnson TD, Meyer CR, Mukherji SK, Quint DJ, Gebarski SS, Fan X, Tsien CI, Lawrence TS, Junck L, Rehemtulla A, Ross BD. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A. 2005 Nov 15; 102(46):16759-64. PMID: [16267128](//www.ncbi.nlm.nih.gov/pubmed/16267128); PMCID: [PMC1276616](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1276616).

Citations:
[127](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16267128/citedby/)
Fields:

Sci Science

Translation:Humans

  142. **Hamstra DA** , Moffat BA, Hall DE, Young JM, Desmond TJ, Carter J, Pietronigro D, Frey KA, Rehemtulla A, Ross BD. Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study. J Neurooncol. 2005 Jul; 73(3):225-38. PMID: [15980973](//www.ncbi.nlm.nih.gov/pubmed/15980973).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15980973/citedby/) Fields:

Neo NeoplasmsNeu Neurology

Translation:HumansAnimals

  143. Hall DE, Moffat BA, Stojanovska J, Johnson TD, Li Z, **Hamstra DA** , Rehemtulla A, Chenevert TL, Carter J, Pietronigro D, Ross BD. Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin Cancer Res. 2004 Dec 01; 10(23):7852-9. PMID: [15585617](//www.ncbi.nlm.nih.gov/pubmed/15585617).

Citations:
[36](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15585617/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  144. **Hamstra DA** , Lee KC, Tychewicz JM, Schepkin VD, Moffat BA, Chen M, Dornfeld KJ, Lawrence TS, Chenevert TL, Ross BD, Gelovani JT, Rehemtulla A. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. Mol Ther. 2004 Nov; 10(5):916-28. PMID: [15509509](//www.ncbi.nlm.nih.gov/pubmed/15509509).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15509509/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:Animals

  145. Rehemtulla A, **Hamstra DA** , Kievit E, Davis MA, Ng EY, Dornfeld K, Lawrence TS. Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme/prodrug therapy. Anticancer Res. 2004 May-Jun; 24(3a):1393-9. PMID: [15274300](//www.ncbi.nlm.nih.gov/pubmed/15274300).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15274300/citedby/) Fields:

Neo Neoplasms

Translation:AnimalsCells

  146. Laxman B, Hall DE, Bhojani MS, **Hamstra DA** , Chenevert TL, Ross BD, Rehemtulla A. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A. 2002 Dec 24; 99(26):16551-5. PMID: [12475931](//www.ncbi.nlm.nih.gov/pubmed/12475931); PMCID: [PMC139181](//www.ncbi.nlm.nih.gov/pmc/articles/PMC139181).

Citations:
[65](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12475931/citedby/) Fields:

Sci Science

Translation:HumansAnimalsCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 146 publications over 22 distinct years, with a maximum of
15 publications in
2015](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|15&cht=bvs&chd=t:0,0,0,0,0,0,0,0,7,0,20,13,27,27,33,20,33,93,47,93,80,100,93,80,60,27,33,27,40,13,7&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2002| 1  
2004| 3  
2005| 2  
2006| 4  
2007| 4  
2008| 5  
2009| 3  
2010| 5  
2011| 14  
2012| 7  
2013| 14  
2014| 12  
2015| 15  
2016| 14  
2017| 12  
2018| 9  
2019| 4  
2020| 5  
2021| 4  
2022| 6  
2023| 2  
2024| 1  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

HAMSTRA's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (430)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Prostatic Neoplasms](https://profiles.viictr.org/profile/245090)
  * [Androgen Antagonists](https://profiles.viictr.org/profile/250920)
  * [Prostate-Specific Antigen](https://profiles.viictr.org/profile/257452)
  * [Rectum](https://profiles.viictr.org/profile/253709)
  * [Prostatectomy](https://profiles.viictr.org/profile/257039)

[Explore](https://profiles.viictr.org/profile/34089599/198)

_

Co-Authors (12)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [KUBAN, DEBORAH A](https://profiles.viictr.org/profile/12583748)
  * [LUDWIG, MICHELLE](https://profiles.viictr.org/profile/2619439)
  * [HANANIA, ALEXANDER](https://profiles.viictr.org/profile/35089783)
  * [GROTH, SHAWN](https://profiles.viictr.org/profile/14348380)
  * [RAO, ARPIT](https://profiles.viictr.org/profile/34493466)

[Explore](https://profiles.viictr.org/profile/34089599/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [FRANK, STEVEN JAY](https://profiles.viictr.org/profile/12582619)
  * [LOGOTHETIS, CHRISTOPHER J](https://profiles.viictr.org/profile/12583246)
  * [KUBAN, DEBORAH A](https://profiles.viictr.org/profile/12583748)
  * [HOFFMAN, KAREN](https://profiles.viictr.org/profile/12583572)
  * [CHAPIN, BRIAN FRANCIS](https://profiles.viictr.org/profile/12582802)

[Explore](https://profiles.viictr.org/profile/34089599/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [CHAPMAN, CHRISTINA](https://profiles.viictr.org/profile/37652178)
  * [CHEN, ALBERT](https://profiles.viictr.org/profile/30445132)
  * [LUDWIG, MICHELLE](https://profiles.viictr.org/profile/2619439)
  * [MORALES RIVERA, KRYSTAL](https://profiles.viictr.org/profile/41694576)
  * [ZHU, ANGELA](https://profiles.viictr.org/profile/266199)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=A81BSfTwU3GNm4liSODkW6vB3EBYO6gz+a5TY1bFhuz1tc7ngL4Orww3064KoquG+9VriFtrDjogfSknlN6Jz7ictMT0qk3g10zM0TMIEPsEyvmx6bLpcnNFGJ4exv4/fFAesBf4NHrkI4nVpsBeSKg1prKuDu5Ad3xZR2IG1VXzQt2Kl5Hs5a708T2/vlG+0DSye5g9KBjG4Q1kuBhnZAsDzRQkDR38klnZT2UlnG774nyA2dru0SIu9XaJe2Vd5sGS5MfW+ZRpNT79jDpQICGGFNfg5WTlXIPkbYJjpf3YGfCjPCJ3A81UJRyGY9MF14VFc7hjK08KUw/CXldSQkQX94mkjqn1GRbJZcV6q8YMdcbUB3UeVgUHmLQA7INKLsictgHvVcL1tc7ngL4Or2BgPoCYhvcEdI9fj5a9U4/8OigV51+oglRnSu//SLHvjH1HWb7OWmYrCEOhNlmBq7Z/PsLHWsJSZIAfV8346VMVWsQSiN3oIGGN9jLXSZC010kNGYH6yvTtuL5pI2IiiZgevCUih0f3vmYbjqDWiC08TnyRrJKGE/Ija0iyg/oaKwhDoTZZgau2fz7Cx1rCUmSAH1fN+OlTFVrEEojd6CBhjfYy10mQtNdJDRmB+sr0qj61OBf+xqDD+6Clu8wvckIBgwTrFvbm7X3tdBvSWESSFAIovZGCSzP0EoNHt5PiUF26eANDXMkWXAx5IRPustF+EEOAWlaZMfmQk2RtrZ/9pJT6x3XUXJPV6yY1gN1AdI9fj5a9U4+aNrG+Mqv3R0Ah6vZbG7FnPjyO/B70o93n31HgwnQ0v//l+ZMiQnZ05dTUbxrT/PiU1/thfvN/wekzor52QqXWWVzXVp6F8zLcXgNSpmzvls56K+e9YVJ0TAHmx4/9MAoiPSt4sYkjfisseztSicCZGxqA1756Bcz8WDCFBS0qHIn8IOnvbDqNdiDMN9cz/RewxWAU9A2KJwOgk6mJ/h/a0nP6VfC1cFSVswx8tp8Pb8VCT++VAWhC1PK0qq0TMrG3yh/cfTgg4g==)

_

